Settsu, Japan

Toshio Matsuda


Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1992-1993

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Toshio Matsuda

Introduction

Toshio Matsuda is a notable inventor based in Settsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anxiolytic drugs. With a total of 3 patents to his name, Matsuda's work has had a meaningful impact on the treatment of anxiety disorders.

Latest Patents

Matsuda's latest patents include innovative compounds such as optically active alkylenedioxybenzene derivatives. These derivatives are characterized by their unique formula, which includes integers m and n that define their structure. Additionally, he has developed a pharmaceutical composition that utilizes these compounds for treating anxiety in warm-blooded animals. Another significant patent involves a piperazine derivative that serves as an active ingredient in anxiolytic drugs, showcasing his commitment to advancing mental health treatments.

Career Highlights

Throughout his career, Matsuda has been associated with Mitsubishi Kasei Corporation, where he has been able to leverage his expertise in chemistry and pharmacology. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the pharmaceutical industry.

Collaborations

Matsuda has collaborated with esteemed colleagues such as Heitaro Iwata and Akemichi Baba. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Toshio Matsuda's contributions to the field of pharmaceuticals, particularly in the development of anxiolytic drugs, highlight his role as a significant inventor. His innovative patents and collaborations reflect his dedication to improving mental health treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…